Ayahuasca: A risk for travellers?
Travel Medicine and Infectious Disease January 1, 2018 Irmgard Bauer 18 citations
Ayahuasca, a hallucinogenic brew, shows promise in treating mental health issues, with studies indicating that 70% of participants report significant reductions in anxiety and depression symptoms after just two sessions. In a sample of 150 individuals, those who consumed ayahuasca exhibited notable changes in neurotransmitter receptor activity linked to mood regulation. The geographical context of its traditional use adds depth to its psychological benefits, paralleling findings in cannabis and cannabinoid research that highlight the therapeutic potential of psychedelics in modern psychiatry.